Next Article in Journal
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)
Previous Article in Journal
Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2023, 15(1), 203; https://doi.org/10.3390/cancers15010203
Action Date Notes Link
article xml file uploaded 29 December 2022 10:27 CET Original file -
article xml uploaded. 29 December 2022 10:27 CET Update -
article pdf uploaded. 29 December 2022 10:27 CET Version of Record https://www.mdpi.com/2072-6694/15/1/203/pdf-vor
article supplementary file uploaded. 29 December 2022 10:27 CET - https://www.mdpi.com/2072-6694/15/1/203#supplementary
article html file updated 29 December 2022 10:29 CET Original file -
article xml file uploaded 30 December 2022 09:25 CET Update -
article xml uploaded. 30 December 2022 09:25 CET Update https://www.mdpi.com/2072-6694/15/1/203/xml
article pdf uploaded. 30 December 2022 09:25 CET Updated version of record https://www.mdpi.com/2072-6694/15/1/203/pdf
article html file updated 30 December 2022 09:26 CET Update -
article html file updated 1 March 2023 06:44 CET Update -
article html file updated 5 March 2023 01:30 CET Update https://www.mdpi.com/2072-6694/15/1/203/html
Back to TopTop